Americana Partners’s GSK GSK Stock Holding History

Americana Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Sell	6,789 -1,617	-19%	-$85.5K	0.01%	448
2026 Q1	$464K	Sell	8,406 -44	-0.5%	-$2.38K	0.01%	359
2025 Q4	$414K	Sell	8,450 -82	-1%	-$3.83K	0.01%	358
2025 Q3	$368K	Sell	8,532 -290	-3%	-$11.3K	0.01%	351
2025 Q2	$339K	Buy	8,822 +601	+7%	+$23K	0.01%	350
2025 Q1	$318K	Sell	8,221 -7,081	-46%	-$259K	0.01%	321
2024 Q4	$518K	Sell	15,302 -43,635	-74%	-$1.57M	0.02%	272
2024 Q3	$2.41M	Buy	58,937 +243	+0.4%	+$9.94K	0.16%	127
2024 Q2	$2.26M	Buy	58,694 +14,039	+31%	+$591K	0.18%	125
2024 Q1	$1.91M	Sell	44,655 -2,433	-5%	-$100K	0.16%	135
2023 Q4	$1.73M	Buy	47,088 +29,043	+161%	+$1.04M	0.16%	123
2023 Q3	$643K	Buy	18,045 +2,267	+14%	+$80.5K	0.07%	183
2023 Q2	$562K	Buy	+15,778	New	+$566K	0.07%	182

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Americana Partners's GSK Position: Q2 2026 in Review

Americana Partners reduced its GSK (GSK) stake by 19% in Q2 2026, selling an estimated $85.5K and leaving 6,789 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #448.

Americana Partners first reported a position in GSK in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.41M in Q3 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Americana Partners held 6,789 shares of GSK worth $356K as of Q2 2026.
Americana Partners sold 1,617 GSK shares in Q2 2026, an estimated $85.5K.
GSK made up 0.01% of Americana Partners's portfolio in Q2 2026, its #448 holding.
Americana Partners first reported a position in GSK in Q2 2023 and has held it in 13 quarters since.
Americana Partners's GSK position peaked at $2.41M in Q3 2024.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.